Rituxan^®

Rituxan^® - The trade name for rituximab, Rituxan^® is a monoclonal antibody used in the treatment of certain types of B-cell non-Hodgkin's lymphoma (NHL) and some other diseases. Administered via injection, Rituxan^® works by selectively targeting and working against the CD20 antigen, found on B cells. Rituxan^® may be used alone or with other cancer treatments, such as chemotherapy.

Previous: Risk Factor

Next: Salivary Gland Cancer

Back to the Cancer Glossary